PetIQ Inc (PETQ) Insider Sells $607,800.00 in Stock

PetIQ Inc (NASDAQ:PETQ) insider Will Santana sold 20,000 shares of PetIQ stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $30.39, for a total value of $607,800.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Will Santana also recently made the following trade(s):

  • On Thursday, April 11th, Will Santana sold 20,000 shares of PetIQ stock. The stock was sold at an average price of $31.06, for a total value of $621,200.00.
  • On Thursday, March 7th, Will Santana sold 20,000 shares of PetIQ stock. The stock was sold at an average price of $25.63, for a total value of $512,600.00.
  • On Wednesday, February 27th, Will Santana sold 20,000 shares of PetIQ stock. The stock was sold at an average price of $30.54, for a total value of $610,800.00.
  • On Wednesday, February 13th, Will Santana sold 20,000 shares of PetIQ stock. The stock was sold at an average price of $29.11, for a total value of $582,200.00.
  • On Thursday, January 24th, Will Santana sold 24,400 shares of PetIQ stock. The stock was sold at an average price of $28.14, for a total value of $686,616.00.
  • On Thursday, January 10th, Will Santana sold 25,000 shares of PetIQ stock. The stock was sold at an average price of $25.04, for a total value of $626,000.00.

Shares of PetIQ stock traded up $0.38 during trading hours on Friday, hitting $30.59. The company’s stock had a trading volume of 272,031 shares, compared to its average volume of 375,383. PetIQ Inc has a 12-month low of $17.56 and a 12-month high of $43.93. The company has a market capitalization of $862.09 million, a price-to-earnings ratio of 24.47, a PEG ratio of 1.41 and a beta of 2.26. The company has a quick ratio of 1.80, a current ratio of 3.24 and a debt-to-equity ratio of 0.34.

PetIQ (NASDAQ:PETQ) last announced its quarterly earnings data on Monday, March 11th. The company reported $0.06 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.07 by ($0.01). PetIQ had a negative net margin of 0.15% and a positive return on equity of 8.53%. The business had revenue of $111.02 million during the quarter, compared to analysts’ expectations of $98.72 million. On average, equities analysts expect that PetIQ Inc will post 0.87 earnings per share for the current year.

Institutional investors have recently made changes to their positions in the company. Wells Fargo & Company MN lifted its position in PetIQ by 122.4% during the 3rd quarter. Wells Fargo & Company MN now owns 101,819 shares of the company’s stock worth $4,002,000 after buying an additional 56,031 shares in the last quarter. JPMorgan Chase & Co. lifted its position in PetIQ by 6,548.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 137,554 shares of the company’s stock valued at $5,407,000 after purchasing an additional 135,485 shares during the period. Alliancebernstein L.P. lifted its position in PetIQ by 580.5% during the 3rd quarter. Alliancebernstein L.P. now owns 86,426 shares of the company’s stock valued at $3,397,000 after purchasing an additional 73,726 shares during the period. Bank of New York Mellon Corp lifted its position in PetIQ by 130.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 194,761 shares of the company’s stock valued at $7,655,000 after purchasing an additional 110,277 shares during the period. Finally, BlackRock Inc. lifted its position in PetIQ by 9.9% during the 3rd quarter. BlackRock Inc. now owns 917,484 shares of the company’s stock valued at $36,066,000 after purchasing an additional 82,449 shares during the period. Institutional investors and hedge funds own 84.33% of the company’s stock.

Several analysts have issued reports on the company. Zacks Investment Research raised PetIQ from a “sell” rating to a “hold” rating in a report on Tuesday, March 12th. ValuEngine lowered PetIQ from a “buy” rating to a “hold” rating in a report on Saturday, March 9th. Raymond James cut their price target on PetIQ from $42.00 to $39.00 and set an “outperform” rating for the company in a report on Monday, March 4th. BidaskClub raised PetIQ from a “buy” rating to a “strong-buy” rating in a report on Friday, January 25th. Finally, Jefferies Financial Group reissued a “buy” rating and set a $39.00 price target on shares of PetIQ in a report on Tuesday, January 15th. Two equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $43.40.

COPYRIGHT VIOLATION WARNING: This news story was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.baseballdailydigest.com/news/2019/04/21/petiq-inc-petq-insider-sells-607800-00-in-stock.html.

PetIQ Company Profile

PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.

Read More: What are trading strategies for the 52-week high/low?

Insider Buying and Selling by Quarter for PetIQ (NASDAQ:PETQ)

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.